Fresenius Medical (FMS) - Kewajiban jangka dawa marang modal

Fresenius Medical - logo grafis emiten FMS

The current price chart for Fresenius Medical Care (FMS) reflects the dynamics of a business that dominates the dialysis segment, operating within a strict duopoly with no risk of new entrants. Fresenius Medical Care (FMS) integrates equipment manufacturing and center management to optimize costs. Stable demand for services and consumables ensures a consistent cash flow, while the 0.71 metric confirms the operational resilience of this healthcare behemoth.

freseniusmedicalcare.com (FMS): Rasio utang jangka dawa marang ekuitas saka 04.07.2022 nganti 30.10.2026
Produk mawa merek Fresenius Medical Care Corp

The sensitivity of this metric to operating cash flows allows for an assessment of the financing structure's stability by measuring the proportion of long-term loans relative to equity to determine the degree of financial autonomy. Optimizing the debt load within the long-term liabilities-to-equity ratio confirms the ability of Fresenius Medical Care to invest in the green modernization of dialysis centers without risking its solvency.

Perusahaan pesaing

HCA: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal THC|SOLV - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal EHC (Encompass Health)|Utang jangka dawa marang modal Universal Health Services Inc UHS|DVA: Rasio utang jangka dawa marang ekuitas|RadNet Inc - Rasio silihan jangka dawa marang modal|Option Care Health Inc (OPCH) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Surgery Partners Group|PINC (Premier, Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal nationalvision.com EYE|Utang jangka dawa marang ekuitas Progyny (PGNY)|Ardent Health - Rasio utang jangka dawa marang modal|Select Medical Corp - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal ASTH (Astrana Corp)|Pediatrix - Utang jangka dawa marang modal|Kewajiban jangka dawa marang ekuitas USPH|The Pennant Group (PNTG) - Utang jangka dawa marang ekuitas|Organogenesis Holdings Inc. - Koefisien utang jangka dawa marang modal|NUTX (Nutex Health Corp) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Auna Corp AUNA|Utang jangka dawa marang ekuitas SBC Medical Group (SBC)|Rasio tanggungan utang jangka dawa marang modal evolus.com|Utang jangka dawa marang modal CYH (Community Health Systems, Inc.)|The Beauty Health Company (SKIN) - Kewajiban jangka dawa marang modal|MDWD - Utang jangka dawa marang ekuitas|BTMD (Biote Corporation) - Rasio utang jangka dawa marang modal|JYNT: Utang jangka dawa marang modal|DCGO - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas PIII|Utang jangka dawa marang modal Gain Therapeutics Inc.|Utang jangka dawa marang ekuitas EUDA Health (EUDA)|Rasio tanggungan utang jangka dawa marang modal baselmedical.com|CollPlant Biotechnologies Ltd. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CUPR|CCM - Utang jangka dawa marang ekuitas|American Shared Hospital Services Inc (AMS) - Rasio utang jangka dawa marang ekuitas|MRM: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Avalon GloboCare Corp. (ALBT)|DHAI (DIH Holding US, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal XAGE (carmellcosmetics.com)|Utang jangka dawa marang modal NIVF|Rasio tanggungan utang jangka dawa marang modal atipt.com|Utang jangka dawa marang modal CMAX (CareMax Medical Group)|KDLY - Rasio utang jangka dawa marang ekuitas|ModivCare Inc. - Utang jangka dawa marang modal|NVOS - Utang jangka dawa marang modal|sunlinkhealth.com (SSY) - Utang jangka dawa marang ekuitas|BACK (IMAC Holdings Inc) - Utang jangka dawa marang ekuitas